Skip to main content
. Author manuscript; available in PMC: 2014 Nov 13.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Jun;14(6):672–684. doi: 10.1016/j.bbmt.2008.03.009

Table 1.

Table 1a. Patient Characteristics by Treatment group in patients treated with BuCy2 or Bu-Flu.
Variable BuCy2 (N=67) Bu-Flu (N=148) P-value
Cytogenetics 1.00
 Others 47 (70.1) 104 (70.3)
 Bad 20 (29.9) 44 (29.7)
Disease Status 0.88
 Others 35 (52.2) 79 (53.4)
 CR 32 (47.8) 69 (46.6)
 CR1 12 (18) 36 (24)
Allo type 0.0003
 Others 14 (20.9) 70 (47.3)
 Sib/Related 53 (79.1) 78 (52.7)
PB blast 0.11
 >0 24 (35.8) 37 (25.0)
 0 43 (64.2) 111 (75.0)
Age 39 (13 – 64) 46 (19 – 66) 0.01
PB PLT 86 (2 – 330) 89 (3 – 463) 0.41
Table 1b. Patient Characteristics by Treatment group in patients treated with MF.
Variable Before 4/18/2001 (N=50) After 4/18/2001 (N=28) P-value
Cytogenetics 0.16
 Others 23 (46.0) 18 (64.3)
 Bad 27 (54.0) 10 (35.7)
Disease Status 0.02
 Others 44 (88.0) 18 (64.3)
 CR 6 (12.0) 10 (35.7)
Allo type 0.24
 Others 32 (64.0) 14 (50.0)
 Sib/Related 18 (36.0) 14 (50.0)
PB blast 0.08
 >0 19 (38.0) 5 (17.9)
 0 31 (62.0) 23 (82.1)
Age 54 (23 – 66) 54 (22 – 74) 0.69
PB PLT 46 (2 – 284) 54 (9 – 377) 0.16
*

Number in each cell is N (%) for categorical variable and median (range) for continuous variable.

Abbreviations: Cyto, cytogenetics; PB, peripheral blood; Allo, allogeneic; Sib, sibling; Rel, related; PLT, platelet; CR, complete remission)